Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells

Experimental and Molecular Pathology

Volumn 93, Issue 3, 2012, Pages 334-338

  Deng, Guoping ^a   Xiao, Yan ^a   Zhou, Zhaocai ^b   Nagai, Yasuhiro ^a   Zhang, Hongtao ^a   Li, Bin ^c   Greene, Mark I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; DISEASE MODEL; GENE MUTATION; GENETIC SUSCEPTIBILITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IPEX SYNDROME; LYMPHOCYTE FUNCTION; NONHUMAN; NUCLEAR IMPORT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

ANIMALS; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICE; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES, REGULATORY;

RODENTIA;

EID: 84870723840     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.09.013     Document Type: Article

References (51)

1. Aarts-Riemens T., et al. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. European Journal of Immunology 2008, 38:1381-1390.
2. Allan S.E., et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. The Journal of Clinical Investigation 2005, 115:3276-3284.
3. Artenstein A.W., Opal S.M. Proprotein convertases in health and disease. The New England Journal of Medicine 2011, 365:2507-2518.
4. Bandukwala H.S., et al. Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity 2011, 34:479-491.
5. Basu S., et al. Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. Journal of Immunology 2008, 180:5794-5798.
6. Bennett C.L., et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA->AAUGAA) leads to the IPEX syndrome. Immunogenetics 2001, 53:435-439.
7. Bettelli E., et al. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:5138-5143.
8. Bettini M.L., et al. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 2012, 36:717-730.
9. Brunkow M.E., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 2001, 27:68-73.
10. Chatila T.A., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. The Journal of Clinical Investigation 2000, 106:R75-R81.
11. Dang E.V., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
12. Darce J., et al. An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 2012, 36:731-741.
13. de Zoeten E.F., et al. Foxp3 processing by proprotein convertases and control of regulatory T cell function. The Journal of Biological Chemistry 2009, 284:5709-5716.
14. Du J., et al. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. Journal of Immunology 2008, 180:4785-4792.
15. Fontenot J.D., et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 2003, 4:330-336.
16. Fontenot J.D., et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
17. Gavin M.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
18. Hancock W.W., Ozkaynak E. Three distinct domains contribute to nuclear transport of murine Foxp3. PLoS One 2009, 4:e7890.
19. Holmes D., et al. FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. The Journal of Biological Chemistry 2007, 282:15973-15980.
20. Hori S., et al. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
21. Ichiyama K., et al. Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. The Journal of Biological Chemistry 2008, 283:17003-17008.
22. Kalderon D., et al. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 1984, 311:33-38.
23. Katoh H., et al. FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1. Molecular Cell 2011, 44:770-784.
24. Khattri R., et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunology 2003, 4:337-342.
25. Kwon H.S., et al. Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells. Journal of Immunology 2012, 188:2712-2721.
26. Lee S.M., et al. FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1. Blood 2008, 111:3599-3606.
27. Li B., Greene M.I. FOXP3 actively represses transcription by recruiting the HAT/HDAC complex. Cell Cycle 2007, 6:1432-1436.
28. Li B., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4571-4576.
29. Lin W., et al. Regulatory T cell development in the absence of functional Foxp3. Nature Immunology 2007, 8:359-368.
30. Loizou L., et al. Foxp3 interacts with c-Rel to mediate NF-kappaB repression. PLoS One 2011, 6:e18670.
31. Lopes J.E., et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. Journal of Immunology 2006, 177:3133-3142.
32. Pan F., et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 2009, 325:1142-1146.
33. Robbins J., et al. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 1991, 64:615-623.
34. Rudra D., et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network 2012, Nature immunology.
35. Seidah N.G., Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Research 1999, 848:45-62.
36. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
37. Smith E.L., et al. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology 2006, 119:203-211.
38. Song X., et al. Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell reports 2012, 1:665-675.
39. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. The Journal of Experimental Medicine 1998, 188:287-296.
40. van der Vliet H.J., Nieuwenhuis E.E. IPEX as a result of mutations in FOXP3. Clinical & Developmental Immunology 2007, 89017. 2007.
41. van Loosdregt J., et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 2010, 115:965-974.
42. van Loosdregt J., et al. Rapid temporal control of Foxp3 protein degradation by sirtuin-1. PLoS One 2011, 6:e19047.
43. Wildin R.S., et al. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. Journal of Medical Genetics 2002, 39:537-545.
44. Wu Y., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
45. Xiao Y., et al. Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Current Opinion in Immunology 2010, 22:583-591.
46. Yagi H., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. International Immunology 2004, 16:1643-1656.
47. Zeng W.P., et al. Domain requirements for the diverse immune regulatory functions of foxp3. Molecular Immunology 2011, 48:1932-1939.
48. Zhang H., et al. Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity. Immunology and Cell Biology 2012, 90:95-100.
49. Zhou L., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
50. Zhou Z., et al. FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity. Immunologic Research 2008, 42:19-28.
51. Ziegler S.F. FOXP3: of mice and men. Annual Review of Immunology 2006, 24:209-226.